Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus, on Oral Hypoglycemic Treatment”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Post-approval studies (Phase 4)Study completedNCT00807092
What this trial is testing

Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 145
Post-approval studies (Phase 4)Study completedNCT00970528
What this trial is testing

Glucose Reduction by Early Acarbose Treatment in Basal Insulin

Who this might be right for
Diabetes Mellitus, Type 2
Bayer 124
Post-approval studies (Phase 4)Study completedNCT04013581
What this trial is testing

Quadruple Oral Combination Therapy for Type 2 Diabetes Mellitus : Glycemic Control by Thiazolidinedione (TZD) or Sodium Glucose Co-transporter 2 (SGLT-2) Inhibitor as an add-on Therapy in Type 2 Diabetes Mellitus After Failure of an Oral Triple Antidiabetic Regimen

Who this might be right for
Type 2 Diabetes Mellitus
Yonsei University 121
Not applicableStudy completedNCT03196154
What this trial is testing

Association Between Insulin Resistance and Beta Cell Function With HbA1C in Diabetics

Who this might be right for
Diabetes Mellitus, Type 2
Clinical Research Centre, Malaysia 255
Not applicableStudy completedNCT00842192
What this trial is testing

An Observational Study in Type 2 Diabetic Patients on Oral Antidiabetic Drugs and Basal Insulin in Near East Countries

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 2,155
Post-approval studies (Phase 4)Study completedNCT00941369
What this trial is testing

Health Assessment, Patient Treatment Satisfaction and Quality-of-Life in Insulin-Naive Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 345
Testing effectiveness (Phase 2)Study completedNCT00382239
What this trial is testing

Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 153
Large-scale testing (Phase 3)Study completedNCT01204294
What this trial is testing

Comprehensive Add on Study in Japan

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 574
Post-approval studies (Phase 4)Study completedNCT01076842
What this trial is testing

Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment

Who this might be right for
Diabetes Type 2
Novo Nordisk A/S 75
Post-approval studies (Phase 4)Looking for participantsNCT06613854
What this trial is testing

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
University Medical Centre Ljubljana 90
Large-scale testing (Phase 3)Study completedNCT01798706
What this trial is testing

Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes
Sanofi 350
Large-scale testing (Phase 3)Not Yet RecruitingNCT07139548
What this trial is testing

RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes

Who this might be right for
T2DM
Guangdong Raynovent Biotech Co., Ltd 600
Not applicableStudy completedNCT01859598
What this trial is testing

Observational Registry for Basal Insulin Treatment Study (ORBIT)

Who this might be right for
Diabetes
The George Institute for Global Health, China 19,894
Large-scale testing (Phase 3)Study completedNCT00673231
What this trial is testing

Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,240
Large-scale testing (Phase 3)Study completedNCT01697592
What this trial is testing

Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 585
Not applicableStudy completedNCT00665808
What this trial is testing

Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-life" Usage in Germany

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 8,125
Post-approval studies (Phase 4)Not Yet RecruitingNCT07173712
What this trial is testing

Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Yanbing Li 324
Not applicableStudy completedNCT00865397
What this trial is testing

Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin Treatment

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 1,032
Post-approval studies (Phase 4)Study completedNCT02606357
What this trial is testing

Treatment of Type 2 Diabetes With Long Acting Basal Insulin in Jordan

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 242
Post-approval studies (Phase 4)Study completedNCT06145360
What this trial is testing

Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient

Who this might be right for
Glucose Metabolism DisordersDiabetes Mellitus, Type 2Hypoglycemic Agents+1 more
SINA Health Education and Welfare Trust 150
Next Page